Describe in details about the aetiopathogenesis and clinical profile of rabies from basics to clinical approach for me to present in my class

Reading File

Finding Sources

Searching PubMed

rabies pathogenesis clinical features diagnosis

Reading File

Loading Image

Reading File

Loading Image

Reading File

Loading Image

I now have comprehensive material across virology, epidemiology, pathogenesis, clinical features, diagnosis, and management from Harrison's, Bradley-Daroff Neurology, Goldman-Cecil, Robbins Pathology, and Sherris Microbiology. Let me compile this into a thorough, well-organized class presentation.

Rabies - Aetiopathogenesis and Clinical Profile

A Comprehensive Class Presentation

1. INTRODUCTION

Rabies is an acute, almost invariably fatal viral encephalitis caused by rabies virus, transmitted to humans via the saliva of infected animals. The word "rabies" derives from the Latin rabere, "to rage," reflecting the appearance of the infected patient. The disease has been recognized for over 3000 years - Aristotle reportedly recognized it could be spread by a rabid dog, and Louis Pasteur developed the first effective vaccine in 1885.

Worldwide, rabies kills an estimated 59,000 people annually, with the vast majority occurring in Asia and Africa, predominantly from dog bites in resource-limited settings. Children and rural populations are disproportionately affected.

Harrison's Principles of Internal Medicine 22E, p. 1694

2. ETIOLOGIC AGENT - THE VIRUS

Classification

Family: Rhabdoviridae
Genus: Lyssavirus
Type species: Rabies virus (RABV)

Structure

Bullet-shaped, enveloped virion, 70 nm × 180 nm
Helical nucleocapsid with a single-stranded, negative-sense RNA genome of 11,932 nucleotides
The genome encodes five proteins:
1. Nucleocapsid (N) protein - encases the RNA
2. Phosphoprotein (P)
3. Matrix (M) protein - inner envelope, links nucleocapsid to envelope
4. Glycoprotein (G) - knob-like surface spikes; elicits neutralizing and hemagglutination-inhibiting antibodies; binds cellular receptors
5. Large (L) polymerase protein - RNA-dependent RNA polymerase

Colorized electron micrograph of the bullet-shaped rabies virion:

Rabies virus electron micrograph - bullet-shaped enveloped particle

Fig: Colorized electron micrograph (×36,700) showing the characteristic bullet-shaped rabies virus with surface glycoprotein projections - Sherris & Ryan's Medical Microbiology 8th Ed.

Key Molecular Features

The G glycoprotein binds to nicotinic acetylcholine receptors (nAChR) and neural cell adhesion molecules (NCAM) on target cells - this is the key tropism determinant
Negative-sense RNA cannot be translated directly; the virion-associated RNA-dependent RNA polymerase must first transcribe it into mRNAs
Strain heterogeneity exists - different variants are associated with specific animal reservoirs (bats, dogs, foxes, skunks), which explains occasional vaccine failure
Six other non-rabies Lyssavirus species can cause a clinically similar picture
Sherris & Ryan's Medical Microbiology 8th Ed., p. 675-677

3. EPIDEMIOLOGY

Global Burden

~59,000 human deaths annually worldwide (WHO estimate)
99% of human rabies globally is transmitted from dogs in countries with endemic canine rabies
Most cases in Asia and Africa; children and rural populations most affected
Latin America has made significant progress in canine rabies elimination

Animal Reservoirs - Two Epizootic Forms

Form	Reservoir
Urban (canine)	Unimmunized dogs and cats
Sylvatic (wildlife)	Bats, skunks, foxes, raccoons, wolves, coyotes

Rodents and rabbits are NOT significant reservoirs.

In the United States, bat rabies variants are responsible for the majority of indigenously acquired human cases (present in all states except Hawaii). The silver-haired and tricolored bat variants predominate. These bats are small; their bites may go unrecognized.

Routes of Transmission

Bite - overwhelmingly the most common; saliva of infected animal introduced into wound
Scratch - with contaminated saliva
Aerosol - extremely rare (bat caves containing millions of bats, laboratory accidents)
Transplantation - corneal and solid-organ transplants from undiagnosed donors (documented in USA, Germany, Kuwait, Syria, China)
Human-to-human - hypothetically possible but extremely rare; barrier precautions warranted for healthcare workers

Harrison's Principles of Internal Medicine 22E, p. 1694-1695

4. PATHOGENESIS

The pathogenesis of rabies is best understood as a stepwise centripetal then centrifugal neuronal journey.

Step-by-Step Pathogenesis

Pathogenesis of rabies showing viral journey from bite wound to brain and centrifugal spread

Fig: Schematic of rabies pathogenesis - Harrison's Principles of Internal Medicine 22E. Steps shown: (1) Virus inoculated at bite; (2) Viral replication in muscle; (3) Binding to nAChR at neuromuscular junction; (4) Retrograde axonal transport; (5) Replication in spinal cord/dorsal root ganglia; (6) Brain infection; (7) Centrifugal spread to salivary glands, cornea, skin.

Step 1 - Inoculation: Virus introduced into muscle/subcutaneous tissue at bite site.

Step 2 - Local replication: Virus replicates at or near the site of inoculation in muscle cells. During most of the long incubation period, the virus remains localized here - this is why early wound cleansing and postexposure prophylaxis (PEP) are effective.

Step 3 - Neuromuscular junction entry: The G glycoprotein binds to nicotinic acetylcholine receptors on postsynaptic membranes at neuromuscular junctions. NCAM serves as an alternative receptor. The virus is internalized; the envelope fuses with the endosomal membrane, and the nucleocapsid is released into the cytoplasm.

Step 4 - Retrograde axonal transport: Virus travels centripetally within peripheral nerve axons via retrograde fast axonal transport (up to ~250 mm/day). There is a ~12-hour delay at each synapse. This neurotropic spread explains the relationship between bite location and incubation period.

Step 5 - Spinal cord/ganglion replication: The virus replicates in motor neurons of the spinal cord and dorsal root ganglia, then rapidly ascends to the brain.

Step 6 - CNS dissemination: Once in the CNS, virus replicates exclusively within gray matter (neurons), causing neuronal dysfunction. Replication is maximal in the brainstem and limbic system. Remarkably, the neuropathological changes are often surprisingly mild relative to the severity of clinical disease - suggesting neuronal dysfunction rather than neuronal death drives the clinical picture.

Step 7 - Centrifugal spread: After CNS infection, virus spreads centrifugally back along nerves to salivary glands (explaining viral presence in saliva), cornea, skin, and other organs. This centrifugal spread to salivary glands enables onward animal-to-animal transmission.

Molecular Mechanisms of Neuronal Dysfunction

Oxidative stress from mitochondrial dysfunction plays a key role
Serotonergic neurons in the brainstem may be implicated in the behavioral changes (aggression in rabid animals)
Brainstem dysfunction disinhibits inspiratory neurons near the nucleus ambiguus, producing the exaggerated respiratory defense reflexes - the basis of hydrophobia and aerophobia
Harrison's Principles of Internal Medicine 22E, p. 1695-1696

5. NEUROPATHOLOGY

Gross

Brain shows intense edema and vascular congestion

Microscopic

Widespread neuronal degeneration with mononuclear inflammatory infiltrate
Most severe in: brainstem > basal ganglia > spinal cord > dorsal root ganglia
Characteristic finding: Negri bodies

Negri Bodies - Pathognomonic Finding

Negri body in hippocampal pyramidal neuron - Robbins Pathology

Fig: Rabies encephalitis. Arrow points to an eosinophilic Negri body in the cytoplasm of a Purkinje cell. Note surrounding inflammatory cells. (Robbins, Cotran & Kumar Pathologic Basis of Disease)

Negri bodies are eosinophilic, cytoplasmic, round-to-oval inclusions found within neurons
Composed of rabies virus proteins and viral RNA (sites of viral replication)
Classically found in:
- Pyramidal neurons of the hippocampus (most classic)
- Purkinje cells of the cerebellum (most frequently demonstrated histologically)
- Less commonly in cortical and brainstem neurons
Important: Not present in ALL cases of rabies - absence does not exclude diagnosis
Immunohistochemistry (IHC) is more sensitive than H&E for detection
Robbins, Cotran & Kumar Pathologic Basis of Disease, p. 1168-1169

6. CLINICAL PROFILE

Incubation Period

Usually 20-90 days (range: few days to > 1 year; rarely > 2 years)
Factors shortening incubation:
- Multiple bites
- Facial/head bites (shorter distance to CNS)
- Deep wounds with high inoculum
- Bite near peripheral nerves
The prolonged incubation is explained by the virus dwelling at the bite site before neural entry

Clinical Phases

Phase 1 - Prodrome (2-10 days)

Non-specific symptoms that are easily missed:

Fever, chills, malaise, fatigue
Headache, anorexia, insomnia
Nausea, vomiting
Anxiety, irritability

Specific early clue: Paresthesias, pain, or pruritus at or near the healed bite site - occurs in 50-80% of patients. This reflects infection of dorsal root or cranial sensory ganglia. This sign, when present, is highly suggestive of rabies.

Phase 2 - Acute Neurological Phase

Two distinct clinical forms:

A. Encephalitic (Furious) Rabies - 80% of cases

The hallmark is early brainstem involvement producing:

Feature	Description
Hydrophobia	Involuntary, painful contraction of the diaphragm, accessory respiratory muscles, larynx, and pharynx triggered by attempting to swallow liquids. The patient develops intense fear of water.
Aerophobia	Same spasm triggered by a draft of air on the face. Highly specific for rabies.
Hypersalivation	Pharyngeal dysfunction + excess saliva = classic "foaming at the mouth"
Agitation/Hyperexcitability	Episodes of agitated arousal alternating with periods of relative lucidity (which become shorter over time)
Autonomic dysfunction	Hypersalivation, gooseflesh, cardiac arrhythmias, priapism, fever (up to 105-107°F)
Hallucinations	Auditory and visual
Seizures	May occur
Combativeness	Extreme agitation

Mechanisms of hydrophobia/aerophobia: Infected brainstem neurons that normally inhibit inspiratory neurons near the nucleus ambiguus fail to do so, creating exaggerated protective reflexes of the respiratory tract when the larynx/pharynx are stimulated.

As disease progresses: increasing frequency of spasms, worsening autonomic instability, then coma within days, followed by death from respiratory failure.

B. Paralytic (Dumb) Rabies - 20% of cases

Early, prominent flaccid muscle weakness, often beginning in the bitten limb
Spreads to produce quadriparesis and facial weakness
Sphincter involvement common
Sensory involvement usually mild
Hydrophobia and aerophobia are typically absent or late
Commonly misdiagnosed as Guillain-Barré syndrome or poliomyelitis (multifocal flaccid paralysis resembling polio)
Patients survive a few days longer than encephalitic form, but multiple organ failure still ensues

Phase 3 - Coma and Death

Whether encephalitic or paralytic, rabies invariably progresses to coma and death, usually from:

Respiratory failure (primary cause)
Cardiac arrhythmias (brainstem/autonomic dysfunction, myocarditis)
SIADH or diabetes insipidus
Non-cardiogenic pulmonary edema
Gastrointestinal hemorrhage
Multiple organ failure

Death typically occurs within 7-14 days of symptom onset without aggressive supportive care.

Virtually no human patient has survived established rabies encephalitis without intensive intervention. The few documented survivors (Milwaukee Protocol) had aggressive experimental immunotherapy/sedation.

Harrison's Principles of Internal Medicine 22E, p. 1696-1697
Bradley and Daroff's Neurology in Clinical Practice, p. 1675-1676
Goldman-Cecil Medicine, p. 4030

7. LABORATORY INVESTIGATIONS AND DIAGNOSIS

Approach to Diagnosis

Diagnosis is based on the clinical presentation + history of animal exposure. Laboratory confirmation follows.

Routine Labs (Usually Normal or Non-specific)

CBC: usually normal
Metabolic panel: usually normal
CSF: Lymphocytic pleocytosis in >50% (usually <100 WBCs/µL), mild protein elevation, normal glucose

Specific Diagnostic Tests

Test	Specimen	Comment
Direct fluorescent antibody (DFA)	Nuchal skin biopsy (hair follicle nerve fibers), brain tissue	Gold standard for antemortem skin biopsy; high sensitivity
RT-PCR	Saliva, CSF, skin biopsy, urine	Highly sensitive; identifies viral variants; multiple samples increase sensitivity
Serum neutralizing antibodies	Serum	Develop late in illness; absence does NOT exclude rabies early
CSF neutralizing antibodies	CSF	Present in >50% during first week; >87% beyond first week; ratio of CSF:serum antibody >1 suggests CNS infection
Virus isolation	Saliva, brain tissue	Definitive but slow; BSL-3 required
Brain biopsy/autopsy IHC	Brain	Negri bodies on H&E (insensitive); IHC for N antigen (highly sensitive)

Neuroimaging (MRI Brain)

Abnormal signal on FLAIR/T2 sequences in:
- Basal ganglia
- Thalamus
- Midbrain
- Pontine nuclei
- Cortex (gray matter)
MRI may be normal early in disease

Key Diagnostic Principle

Repeat testing on multiple occasions and specimens increases sensitivity - a single negative result does not exclude rabies
The WHO recommends testing saliva, nuchal skin biopsy, and CSF simultaneously
Harrison's Principles of Internal Medicine 22E, p. 1696
Goldman-Cecil Medicine, p. 4030-4031

8. CLINICAL APPROACH AND MANAGEMENT

A. Postexposure Prophylaxis (PEP) - The Most Critical Intervention

PEP must begin immediately after any potential exposure, before symptom onset. Once symptoms appear, PEP is ineffective.

Steps of PEP:

1. Wound Care (Immediate)

Wash wound thoroughly with soap and water for at least 15 minutes
Apply povidone-iodine or 70% ethanol
Do NOT suture wound primarily if possible (delays local virus spread)

2. Risk Assessment - Does the patient need PEP?

Animal	Action
Dog/cat (healthy, available for observation)	Observe for 10 days; start PEP only if animal shows signs
Dog/cat (escaped, unavailable)	Start PEP immediately
Wild animal (bat, raccoon, skunk, fox, coyote)	Start PEP immediately; test animal if captured
Rodent, rabbit	Usually not indicated (consult public health)

3. Rabies Immunoglobulin (RIG)

Human Rabies Immunoglobulin (HRIG): 20 IU/kg
Equine RIG (ERIG): 40 IU/kg (lower cost, available in many countries)
Maximum dose infiltrated around and into the wound - remainder given IM at site distant from vaccine
Provides passive immunity during the window before active vaccine response
Must be given on Day 0 with first vaccine dose
HRIG and vaccine must be given at two different anatomical sites
If previously vaccinated: no RIG needed

4. Active Immunization - Rabies Vaccine

For previously unvaccinated:

Days 0, 3, 7, and 14 - 4 doses IM (WHO/CDC schedule)
Previously: 5-dose schedule (Days 0, 3, 7, 14, 28) - now updated

For previously vaccinated (previously received complete pre/postexposure series):

Days 0 and 3 only (2 doses), no RIG needed

B. Treatment of Established Rabies

Once clinical symptoms develop, there is no proven effective therapy. Management is largely supportive and palliative:

Intensive care unit admission
Mechanical ventilation for respiratory failure
Sedation and anticonvulsants for agitation/seizures
Autonomic management (arrhythmia control)
Nutritional support

Milwaukee Protocol: An experimental approach involving therapeutic coma (ketamine + midazolam), antiviral drugs (ribavirin, amantadine), and vaccine. A handful of patients have survived without prior vaccination, but the protocol has had mixed results and remains controversial.

C. Pre-Exposure Prophylaxis (PrEP)

Recommended for:

Veterinarians and animal handlers
Travelers to endemic regions
Laboratory workers handling virus
Spelunkers (cave explorers)

Schedule: Days 0, 7, 21 or 28 (3 doses IM or intradermal)

Harrison's Principles of Internal Medicine 22E, p. 1697-1699
Sherris & Ryan's Medical Microbiology 8th Ed., p. 679

9. DIFFERENTIAL DIAGNOSIS

Rabies should be distinguished from:

Condition	Distinguishing Features
Tetanus	Trismus, risus sardonicus; no hydrophobia; organism detectable; normal CSF
Guillain-Barré Syndrome	Ascending paralysis (no encephalopathy); albuminocytological dissociation in CSF
Viral encephalitis (HSV, JE)	No hydrophobia/aerophobia; different exposure history; CSF PCR
Psychiatric illness	No fever, normal CSF, no exposure history
Delirium tremens	Alcohol history, no animal bite, no hydrophobia

10. SUMMARY FRAMEWORK FOR CLASS

RABIES
├── Virus: Rhabdoviridae > Lyssavirus; bullet-shaped; (-)ssRNA; G-protein key for receptor binding
├── Epidemiology: 59,000 deaths/yr; dog bites (global); bats (USA); zoonosis
├── Pathogenesis (centripetal → centrifugal)
│   Bite → local replication → nAChR binding at NMJ → retrograde axonal transport
│   → Spinal cord/DRG → Brain (gray matter, brainstem/limbic) → centrifugal spread (salivary glands)
├── Pathology: Negri bodies (hippocampus/Purkinje cells); minimal neuronal death; dysfunction-based disease
├── Clinical
│   Incubation: 20-90 days (inversely related to distance from CNS)
│   Prodrome: fever, malaise + PARESTHESIAS AT BITE SITE (pathognomonic hint)
│   Encephalitic (80%): hydrophobia, aerophobia, foaming, agitation, hypersalivation, autonomic storm
│   Paralytic (20%): flaccid ascending paralysis; mimics GBS; no hydrophobia
│   Coma → Death (respiratory failure)
├── Diagnosis: DFA + RT-PCR (saliva/skin/CSF); MRI; serology (late)
└── Management
    PEP (most important!): wound wash + RIG (HRIG 20 IU/kg) + vaccine (days 0,3,7,14)
    Established disease: supportive; near-universally fatal

SOURCES

Harrison's Principles of Internal Medicine 22E (2025), Chapter 214, pp. 1693-1700
Bradley and Daroff's Neurology in Clinical Practice, Chapter 78, pp. 1675-1677
Goldman-Cecil Medicine International Edition, Chapter 413, pp. 4030-4031
Robbins, Cotran & Kumar Pathologic Basis of Disease, Chapter 28, pp. 1168-1169
Sherris & Ryan's Medical Microbiology 8th Edition, Chapter 17, pp. 675-680

There is a ~12-hour delay at each synapse. This neurotropic spread explains the relationship between bite location and incubation period.

Yes, exactly — that point connects two key concepts. Let me break it down clearly:

The Synaptic Delay and Incubation Period

How the Virus Travels

Rabies virus does not travel as a free particle in the bloodstream. It travels inside axons via retrograde fast axonal transport at up to ~250 mm/day. At every synapse it crosses, there is a ~12-hour delay — this is the time needed for the virus to:

Be released from the presynaptic terminal
Bind to receptors on the next neuron
Be internalized and begin retrograde transport again

Why Bite Location Determines Incubation

The more synapses and the greater the axonal distance between the bite site and the CNS, the longer the incubation period.

Bite Location	Distance to CNS	Number of Synapses	Incubation
Face / head	Very short	Few	Shorter (weeks)
Upper limb	Moderate	Moderate	Intermediate
Lower limb / foot	Long	Many	Longer (months)

This is why a bite to the face or neck is considered particularly dangerous — the virus reaches the brainstem faster, leaving less time for PEP to work.

Clinical Implication

The long incubation for distal bites is actually protective in a practical sense — it gives a larger window for postexposure prophylaxis (PEP) to generate neutralizing antibodies before the virus enters the CNS. Once the virus is inside the axon traveling toward the CNS, it is largely hidden from the immune system — antibodies cannot reach it there. This is why PEP becomes ineffective once neurological symptoms begin.

In short: the synaptic delay is not just a trivia point — it is the mechanistic reason that incubation period, clinical urgency, and the window for prophylaxis all vary with bite location.

Generate a presentation slide on the synaptic delay mechanism and its clinical implications

Reading File

Running Command

Writing File

Running Command

Your presentation is ready. Here's the download link:

Rabies Synaptic Delay

Presentation · PPTX

The deck has 5 slides built in a dark navy + red/teal/gold medical theme:

Slide	Content
1 - Title	Full title slide with the three key numbers as a callout bar (12 hrs, 250 mm/day, incubation ∝ distance)
2 - The Mechanism	5 numbered step-by-step panels: inoculation → nAChR binding → axonal transport → 12-hr synaptic delay → CNS ascent
3 - Bite Location vs Incubation	Colour-coded table (face = extreme/red, upper limb = orange, lower limb = green) + two insight boxes explaining why each end matters
4 - Clinical Implications	Two panels (immune evasion vs PEP window) + 3 takeaway cards + a full-width timeline bar showing exactly where PEP works and where it fails
5 - Summary	Three big-number stat cards + 4 bullet takeaways covering immune evasion, location urgency, the opportunity window, and the 3-step PEP protocol

This is a shared conversation. Sign in to Orris to start your own chat.